Kate L. Sheehan

Evidence for Increased Dopaminergic and Opioid Activity in Patients with Hypothalamic Hypogonadotropic Amenorrhea*

M. E. QUIGLEY, Kate L. Sheehan, Robert F. Casper et al. · The Journal of Clinical Endocrinology & Metabolism · 1980 · 204 citations

Hormonal Contraceptive, Receptor Antagonist, Prl Release +20

Effects of maternal smoking on circulating catecholamine levels and fetal heart rates

M. E. QUIGLEY, Kate L. Sheehan, Mahlon M. Wilkes et al. · American Journal of Obstetrics and Gynecology · 1979 · 109 citations

Tobacco Control, Maternal Cardiovascular Outcome, Nicotine +11

Evidence for an Increased Opioid Inhibition of Luteinizing Hormone Secretion in Hyperprolactinemic Patients with Pituitary Microadenoma*

M. E. QUIGLEY, Kate L. Sheehan, Robert F. Casper et al. · The Journal of Clinical Endocrinology & Metabolism · 1980 · 104 citations

Gynecology, Hormone Secretion, Reproductive Endocrinology +16

Decoupled effects (positive to negative) of nutrient enrichment on ecosystem services

Andrea Antón, Just Cebrián, Kenneth L. Heck et al. · Ecological Applications · 2010 · 96 citations

Biogeochemistry, Eutrophication, Engineering +12

Luteal Phase Defects Induced by an Agonist of Luteinizing Hormone-Releasing Factor: A Model for Fertility Control

Kate L. Sheehan, Robert F. Casper, S. S. C. YEN · Science · 1982 · 87 citations

Hormonal Contraceptive, Fertility, Reproductive Health +18